Blog

In the volatile world of digital asset and fintech companies, investor trust hinges on financial integrity and strong regulatory compliance. For ALT5 Sigma Corporation (NASDAQ: ALTS), a series of catastrophic, self-disclosed events has shattered that trust, triggering an investigation into whether the company misled investors about the very stability of its operations.

By Reed R. Kathrein A critical legal battle is currently unfolding in the Ninth Circuit Court of Appeals—one that strikes at the heart of investor protection under the Securities Act of 1933. In Hunt v. PricewaterhouseCoopers LLP (PwC), No. 24-3568, investors have brought suit against PwC, the auditor of Bloom Energy, alleging that the firm certified financial statements that contained material errors and ultimately required restatement.

For a major building materials producer like James Hardie Industries plc (NYSE: JHX), the health of its business relies on consistent demand from its core customers—the distributors and builders who use its fiber cement products.

In the world of digital advertising, a company’s success is determined not just by user numbers, but by the invisible engines running beneath the surface: its ad technology, its algorithms, and the reliability of its platform. For tech giants like Snap Inc.

The recent securities fraud class action lawsuit against Nutex Health Inc. (NUTX) offers a stark reminder to investors: sometimes, stellar revenue growth can be built on shaky ground.

In the world of health insurance, the value proposition is built on trust. Consumers, particularly those navigating complex plans like Medicare, rely on brokers to be neutral, transparent, and unbiased. The promise is simple: the broker will help you find the best plan for your needs, not their own.

In the high-stakes world of small and mid-sized pharmaceutical companies, a single drug can make or break a company’s market valuation. Unlike established, large-cap pharmaceutical giants with diverse portfolios, these smaller biotech firms often have a limited number of drug candidates in the pipeline.

In the world of publicly traded companies, information is a currency. While many disclosures are mandated, companies often choose to voluntarily share additional details to give investors a clearer picture of their business. This can include information about major partnerships or key customers.

SEC collects Wall Street's private messages as WhatsApp probe escalates REUTERS

SEC Awards Whistleblower More Than $9 Million SEC

Michigan Vascular Surgeon Sentenced to 80 Months in Prison for Health Care Fraud Conviction and Agrees to Pay Up to $43.419 Million to Resolve False Claims Act Allegations DOJ

Brazilian Mining Company to Pay $55.9 Million to Settle Charges Related to Misleading Disclosures Prior to Deadly Dam Collapse SEC

Former Goldman banker must forfeit $35.1 mln in 1MDB corruption case REUTERS A U.S. judge on Friday ordered former Goldman Sachs Group Inc (GS.N) banker Roger Ng to forfeit $35.1 million, after sentencing him to 10 years in prison for helping loot billions of dollars from Malaysia's 1MDB sovereign wealth fund. read more »

The SEC charges Lindsay Lohan, Jake Paul and others with illegally promoting crypto NPR

Two Men Sentenced in $30M Foreign Exchange Fraud Scheme DOJ

CEO of Publicly Traded Health Care Company Charged for Insider Trading Scheme DOJ

James L. Luketich, M.D., University of Pittsburgh Medical Center, and University of Pittsburgh Physicians Agree to Pay $8.5 Million and Implement Monitoring Actions to Resolve False Claims Allegations. DOJ

Landlord and Former Operators of Upstate New York Nursing Home Pay $7,168,000 to Resolve False Claims Act Allegations of Worthless Services Provided to Residents DOJ

SEC asks big hedge funds for employee phone review REUTERS The U.S. Securities and Exchange Commission has asked some major hedge funds to review certain employees' personal mobile phones for evidence of business dealings on unapproved channels, Bloomberg News reported on Thursday. read more »